Format

Send to

Choose Destination
Cureus. 2019 Jul 8;11(7):e5097. doi: 10.7759/cureus.5097.

Outlasting a Rare Duodenal Angiosarcoma.

Author information

1
Clinical Obesity Medicine, NYU Langone Health, New York, USA.
2
Pathology, Pali Momi Medical Center, Affiliate of Hawai'i Pacific Health, Honolulu, USA.
3
Oncology, Pali Momi Medical Center, Affiliate of Hawai'i Pacific Health, Honolulu, USA.
4
Gastroenterology, Pali Momi Medical Center, Affiliate of Hawai'i Pacific Health, Honolulu, USA.

Abstract

With current life expectancies exceeding 78 years on average, to be confronted with the discovery of a rare cancer often found in advanced stages is a startling devastation. Angiosarcoma of the intestine is a rare and aggressive tumor that is not often considered in the differential diagnosis of intestinal obstruction. Once found and accurately diagnosed, it is a bewildering race against time as its median survival time is 150 days from diagnosis. This case report details a rare small intestinal angiosarcoma with its host surpassing current epidemiological standards of survival time despite only being eligible for chemotherapy.

KEYWORDS:

angiosarcoma; duodenal angiosarcoma; gastroenterology; small intestine angiosarcoma

Conflict of interest statement

The authors have declared that no competing interests exist.

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center